High-sensitivity cardiac troponin I

There are 30 papers on high-sensitivity cardiac troponin I in aging research: 4 trials and 23 observational studies in people, 1 in animals, 2 reviews. The newest story, Nov 21, 2026: “Stress response linked to airway muscle recovery in mice”.

Biomarker

30 papers study it86 more mention it27 findings

22 new papers in 30 daysSee all 116 papers on high-sensitivity cardiac troponin I

“hs-cTnI concentrations were significantly and independently associated with sex, age, eGFR and CVD in uni- and multivariable analyses”
Proposition of reference tables for hs-cTnI to define “normal” considering relevant determinants in the general populationESC Congress 2026 abstract2026doi:10.1093/eurheartj/ehag785.3186
  • Human trial4
  • Humans23
  • Animals1

Interventions

4

Obesity

upin humans1

1 study
  1. Obesity is linked with higher high-sensitivity cardiac troponin I in humans (per additional year of obesity duration) (0.41% higher per additional year (95% CI 0.07-0.76)).

    Humansper additional year of obesity duration

    More years of obesity linked to heart stress and injury markers

    medRxivPreprint

More on Obesity

SGLT2 inhibitors

no changein humans1

1 study
  1. SGLT2 inhibitors showed no clear effect on high-sensitivity cardiac troponin I in humans (acute myocardial infarction).

    Reviewacute myocardial infarction

More on SGLT2 inhibitors

Cholecalciferol

no changein humans1

1 study
  1. Cholecalciferol showed no clear effect on high-sensitivity cardiac troponin I in humans (older adults with low serum 25-hydroxyvitamin D concentrations (10-29 ng/mL)) (1.6 %-difference (95 % CI: -5.3, 8.9)).

    Human trialolder adults with low serum 25-hydroxyvitamin D concentrations (10-29 ng/mL)doses ≥1,000 IU/ day vs 200 IU/day24 monthsn = 688

More on Cholecalciferol

Vitamin D

no changein humans1

1 study
  1. Vitamin D showed no clear effect on high-sensitivity cardiac troponin I in humans (community-based older adults) (aRD=1.03, 95%CI=0.97-1.09).

    Human trialcommunity-based older adultsplasmamonthly 100,000-IUmean follow-up of 1.6 yearsn = 779

More on Vitamin D

Effects

2

Timed Up and Go

downin humans1

1 study
  1. High-sensitivity cardiac troponin I is linked with worse timed Up and Go in humans (10.3 s vs 9.5 s, p=0.032).

    Humansfemales

Coronary heart disease risk reclassification

upin humans1

1 study
  1. High-sensitivity cardiac troponin I is linked with better coronary heart disease risk reclassification in humans (Addition to a model containing the ATP-III Framingham risk score in asymptomatic adults) (Category-based net reclassification index 18% (95% CI 8%–30%); c-statistic 0.68 to 0.70 (p=0.16)).

    HumansAddition to a model containing the ATP-III Framingham risk score in asymptomatic adultsserumMedian follow-up of 11.3 yearsn = 1,135

Upstream

3

Orthostatic hypotension

no changein humans1

1 study
  1. Orthostatic hypotension was not clearly linked with high-sensitivity cardiac troponin I in humans.

    Humansn = 674

Standing hypertension

upin humans1

1 study
  1. Standing hypertension is linked with higher high-sensitivity cardiac troponin I in humans (8.6% (95% CI 2.7-14.9)).

    Humansn = 674

Seated hypertension

upin humans1

1 study
  1. Seated hypertension is linked with higher high-sensitivity cardiac troponin I in humans (10.1% (95% CI 3.8-16.9)).

    Humansn = 674

Associations

13

Cardiovascular disease

upin humans2mixedin humans1

3 studies
  1. Cardiovascular disease is associated with high-sensitivity cardiac troponin I in humans (General population; univariable and multivariable analyses).

    HumansGeneral population; univariable and multivariable analyses48.9% femalesn = 15,351

  2. High-sensitivity cardiac troponin I is associated with cardiovascular disease in humans (Third trimester of pregnancy).

    HumansThird trimester of pregnancyMedian follow-up of 11.9 yearsfemalesn = 2,056

  3. High-sensitivity cardiac troponin I is associated with cardiovascular disease in humans.

    Humansup to 10 yearsn = 5,764

More on Cardiovascular disease

Coronary artery disease

upin humans2

2 studies
  1. High-sensitivity cardiac troponin I predicts coronary artery disease in humans (normalized for myocardial mass, age and renal function).

    Humansnormalized for myocardial mass, age and renal functionmyocardiumn = 1,613

  2. High-sensitivity cardiac troponin I is associated with coronary artery disease in humans (coronary calcium score ≥100).

    Humanscoronary calcium score ≥100myocardiumn = 1,613

  3. High-sensitivity cardiac troponin I is associated with coronary artery disease in humans.

    Humansup to 10 yearsn = 5,764

More on Coronary artery disease

Mortality

upin humans2

2 studies
  1. High-sensitivity cardiac troponin I predicts mortality in humans (Adjusted for age, sex and traditional cardiovascular risk factors).

    HumansAdjusted for age, sex and traditional cardiovascular risk factorsMedian follow-up 4.4 years48.9% femalesn = 14,361

    A sensitive heart test better predicts death and cardiac events

    ESC Congress 2026 abstract
  2. High-sensitivity cardiac troponin I is associated with mortality in humans.

    Humansup to 10 yearsn = 5,764

Heart failure hospitalization

upin humans1HR 4.2

1 study
  1. High-sensitivity cardiac troponin I is associated with heart failure hospitalization in humans (HR 4.20, 95% CI 3.28–5.37).

    ReviewARIC; highest hs-TnI quintile (≥3.8 ng/L) versus lowest (≤1.3 ng/L); multivariable-adjusted

Major adverse cardiac events

upin humans1HR 1.74

1 study
  1. High-sensitivity cardiac troponin I is associated with major adverse cardiac events in humans (Healthy older ASPREE participants; hs-cTnI >36 ng/L) (HR 1.74; 95% CI 1.07–2.81).

    HumansHealthy older ASPREE participants; hs-cTnI >36 ng/L10 years46.5% malesn = 11,889

Estimated glomerular filtration rate

mixedin humans1

1 study
  1. Estimated glomerular filtration rate is associated with high-sensitivity cardiac troponin I in humans (General population; univariable and multivariable analyses).

    HumansGeneral population; univariable and multivariable analyses48.9% femalesn = 15,351

More on Estimated glomerular filtration rate

Age

mixedin humans1

1 study
  1. Age is associated with high-sensitivity cardiac troponin I in humans (General population; univariable and multivariable analyses).

    HumansGeneral population; univariable and multivariable analyses48.9% femalesn = 15,351

Sex

mixedin humans1

1 study
  1. Sex is associated with high-sensitivity cardiac troponin I in humans (General population; univariable and multivariable analyses).

    HumansGeneral population; univariable and multivariable analyses48.9% femalesn = 15,351

Major adverse cardiovascular events

upin humans1

1 study
  1. High-sensitivity cardiac troponin I predicts major adverse cardiovascular events in humans (Adjusted for age, sex and traditional cardiovascular risk factors).

    HumansAdjusted for age, sex and traditional cardiovascular risk factorsMedian follow-up 4.4 years48.9% femalesn = 14,361

    A sensitive heart test better predicts death and cardiac events

    ESC Congress 2026 abstract

Atrial fibrillation

upin humans1HR 1.84

1 study
  1. High-sensitivity cardiac troponin I is linked with a higher risk of atrial fibrillation in adults with hypertension (HR 1.84, 95% CI 1.30-2.60).

    Humansin adults with hypertensionmedian 3.76 yearsn = 7,261

More on Atrial fibrillation

All 13

Latest

Dec 2025: 3Jan 2026: 7Feb 2026: 9Mar 2026: 3Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 4Sep 2026: 3Oct 2026: 13Nov 2026: 953 papers in 12 months
Journal of Translational Medicine

Stress response linked to airway muscle recovery in mice

Male mice with diet-induced obesity swam for 12 weeks and showed greater improvements in airway muscle force than mice switched to standard chow.Male mice with diet-induced obesity swam for 12 weeks and showed greater improvements in airway muscle force than mice switched to standard chow.

Mouse studyMuscle
ESC Congress 2026 Abstract

A sensitive heart test better predicts death and cardiac events

In 14,361 adults followed for 4.4 years, a next-generation test for a heart-damage protein predicted deaths and cardiovascular events better than an established test.In 14,361 adults followed for 4.4 years, a next-generation test for a heart-damage protein predicted deaths and cardiovascular events better than an established test.

Cohort · 14,361 peopleBiomarkers

See all 116 papers on high-sensitivity cardiac troponin I